S. Hosoglu, E. Arslan, E. Aslan, and Özcan Deveci, “Use of carbapenems and glycopepdides is significant risk for multidrug resistant Acinetobacter baumannii infections”, J Infect Dev Ctries, vol. 12, no. 02, pp. 67–72, Feb. 2018.